MYR Pharmaceuticals Logo (WIPO, 26.10.2020)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke MYR Pharmaceuticals wurde als Bildmarke am 26.10.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Dreiecke, Linien, die einen Winkel bilden #Briefe, die eine besondere Form des Schreibens darstellen #Farben
| Markenform | Bildmarke |
| Aktenzeichen | 1591282A |
| Länder | 
|
| Anmeldedatum | 26. Oktober 2020 |
| Ablaufdatum | 26. Oktober 2030 |
Markeninhaber
Burgwedel,
Fraunhoferstr. 17
DE
Fraunhoferstr. 17
DE
Markenvertreter
Attn: Gretchen R. Stroud,
333 Lakeside Drive
US
Waren und Dienstleistungen
01
Chemicals for use in industry and science; peptides
substrates for scientific and industrial purposes;
oligopeptides; polypeptides; proteins [raw material];
polynucleotides [chemicals for scientific purposes];
oligonucleotides [chemicals for scientific purposes];
nucleic acids; SiRNA molecules; small molecules having a
molar mass of 160 to 480 [for scientific purposes]
09
Scientific, surveying, weighing, measuring apparatus and
instruments, apparatus and instruments for scientific
research, in particular scientific research in laboratories;
data processing apparatus; computers; CDs; DVDs; digital
recording media; computer software
42
Scientific and technological services and research and
design relating thereto; industrial analysis services;
industrial research services, scientific research for
medical, chemical, biological, veterinary and pharmaceutical
purposes; scientific and technological services and research
and design related thereto in the field of hepatitis B;
scientific and technological services and research and
design related thereto in the field of hepatitis D;
scientific and technological services and research and
design related thereto in the field of dyslipidemia;
scientific and technological services and research and
design related thereto in the field of nonalcoholic
steatohepatitis (NASH); scientific and technological
services and research and design related thereto in the
field of primary biliary cholangitis [PBC]; scientific and
technological services and research and design related
thereto in the field of inflammatory diseases; scientific
and technological services and research and design related
thereto in the field of inflammatory diseases inhibiting
sodium-taurocholate co-transporting polypeptide [NTCP];
scientific and technological services and research and
design related thereto in the field of metabolic diseases;
scientific and technological services and research and
design related thereto in the field of metabolic diseases
inhibiting sodium-taurocholate co-transporting polypeptide
[NTCP]; design and development of computer hardware and
software; scientific and technological services in the field
of preclinical development, in particular related to
hepatitis B, hepatitis D, dyslipidemia, nonalcoholic
steatohepatitis [NASH], inflammatory diseases, inflammatory
diseases inhibiting sodium-taurocholate co-transporting
polypeptide [NTCP], primary biliary cholangitis [PBC],
metabolic diseases, and metabolic diseases inhibiting
sodium-taurocholate co-transporting polypeptide [NTCP];
scientific and technological services in the field of
clinical development, in particular related to hepatitis B,
hepatitis D, dyslipidemia, nonalcoholic steatohepatitis
[NASH], primary biliary cholangitis [PBC], inflammatory
diseases, inflammatory diseases inhibiting
sodium-taurocholate co-transporting polypeptide [NTCP],
metabolic diseases, and metabolic diseases inhibiting
sodium-taurocholate co-transporting polypeptide [MVP]
44
Medical services; veterinary services; medical and
veterinary services, in particular medical analysis in
connection with the treatment of individuals; providing
information in the medical field, veterinary field and
pharmacology; services of health centres; services of
clinics (ambulances); therapy services; hygienic and beauty
care for human beings and animals
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 17. September 2022 | 2022/39 Gaz | RAW: Limitation | |
| 25. Mai 2022 | 2022/22 Gaz | MY | Ablehnung |
ID: 999914159128265